WELL Health Technologies (WELL) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
3 Feb, 2026Opening remarks and agenda
Meeting called to order by the chairman, with appointments for secretary, scrutineer, moderator, and legal formalities established.
Rules for virtual meeting conduct and electronic voting procedures were outlined for orderly proceedings.
The agenda was set according to the Management Information Circular dated May 3, 2024.
Corporate governance
Quorum was confirmed, and proof of proper notice and mailing was filed and annexed to the minutes.
The number of directors was set at six, with all nominated directors confirming their willingness to serve.
Election of directors proceeded with no other nominations or questions from shareholders.
Board and executive committee updates
Six directors were nominated and elected to serve until the next annual meeting or until successors are appointed.
Latest events from WELL Health Technologies
- Record Q2 revenue, raised guidance, and AI-driven strategy fuel strong growth and profitability.WELL
Q2 20241 Feb 2026 - Record Q3-2024 revenue and EBITDA growth, raised guidance, and robust M&A pipeline support outlook.WELL
Q3 202415 Jan 2026 - Record revenue, strong Canadian growth, and robust 2025 outlook despite one-time impacts.WELL
Q4 20242 Dec 2025 - Record Q2 revenue and EBITDA growth driven by acquisitions and digital health expansion.WELL
Q2 202523 Nov 2025 - Q1 revenue up 32% to $294.1M, net loss $41.9M, Canadian focus and strong 2025 outlook.WELL
Q1 202518 Nov 2025 - Record Q3 revenue and EBITDA, strong Canadian growth, and robust M&A pipeline for 2025.WELL
Q3 202513 Nov 2025 - WELL Health leverages technology, AI, and capital discipline to drive growth and unlock shareholder value.WELL
Investor Day 2024 Presentation13 Jun 2025